Dose deliveries for new order expected to occur from October 2021 through April 2022 NEW YORK & MAINZ, Germany - Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine. These doses are expected to be delivered from October 2021 through April 2022. This … [Read more...] about Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Company’s SARS-CoV-2/COVID-19 Test (AvellinoCoV2) - One of the First COVID-19 Tests to Receive EUA - Continues to Play Critical Role in Public Health Efforts MENLO PARK, Calif. - Avellino Lab USA, Inc. (Avellino) today announced that more than two million of its SARS-CoV-2/COVID-19 tests (AvellinoCoV2) have now been performed in the United States. Avellino was one of the … [Read more...] about Avellino Surpasses Two Million COVID-19 Tests in United States